Currently browsing tag

european-union

Shire on a roll as U.S. approves keenly awaited eye drug

Shire has won U.S. approval for its most important new medicine, a treatment for dry eyes, in a fresh boost for the company which completed its $32 billion acquisition of U.S. rare diseases specialist Baxalta last month. The Dublin-based drugmaker has been a big stock market winner following Britain's decision to leave the European Union, benefiting from the strength of the dollar against sterling and investor demand for defensive sectors like pharmaceuticals. Shire shares — already up a fifth since the UK referendum on June 23 — gained another 4 percent on Tuesday on news the U.S. Food and Drug Administration had approved lifitegrast eye drops for treating signs and symptoms of dry eye disease.

Conde faces battle to revive Guinea economy after reelection

By Saliou Samb CONAKRY (Reuters) – Guinean President Alpha Conde's emphatic reelection appears to have subdued a combative opposition but a lingering Ebola outbreak and a slump in metals prices are dogging his plan to revive the West African state's economy. European Union observers gave the election a clean bill of health, despite organisational shortcomings, and the main opposition leader Cellou Dallein Diallo has not appealed to Constitutional Court against Conde's victory, although he has until Tuesday to do so.